Personal tools
Document Actions

List of scientific publications

The table below lists all the scientific publications published on FibroTest, ActiTest, SteatoTest, AshTest, NashTest and FibroMax.

There are both the studies published by our teams but also independent studies.

Year Journal Author(s) Title
2001 Lancet Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T; MULTIVIRC Group. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.
2002 Journal of Viral Hepatitis Poynard T, Imbert-Bismut F, Ratziu V, Chevret S, Jardel C, Moussalli J, Messous D, Degos F Biochemical markers of liver fibrosis in patients infected by Hepatitis C Virus: Longitudinal validation in a randomized trial.
2002 American Journal of Gastroenterology Myers RP, Ratziu V, Charlotte F, Imbert-Bismut F, Poynard T Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C
2002 Comparative Hepatology Halfon P, Imbert-Bismut F, Messous D, Antoniotti G, Benchetrit D, Cart-Lamy P, Delaporte G, Doutheau D, Klump T, Sala M, Thibaud D, Trepo E, Robert P. Myers RP, Poynard T. A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease.
2003 Digestive Diseases and Science Myers RP, de Torres M, Imbert-Bismut F, Ratziu V, Charlotte F, Poynard T. Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count and the age-platelet index
2003 Clinical Chemistry Rossi E, Adams L, Prins A, Bulsara M, De Boer B, Garas G, MacQuillan G, Speers D, Jeffrey G Validation of the FibroTest Biochemical Markers Score in Assessing Liver Fibrosis in Hepatitis C Patients
2003 Clinical Chemistry Poynard T, Imbert-Bismut F, Ratziu V, Myers RP, Di Martino V, Thabut D, Moussalli J, Benhamou Y Fibrotest even better than liver biopsy ?
2003 AIDS Myers RP, Benhamou Y, Imbert-Bismut F, Thibault V, Bochet M, Charlotte F, Ratziu V, Bricaire F, Katlama C, Poynard T. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus-coinfected patients.
2003 Gut Poynard T. Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C.
2003 Hepatology Thabut D, Simon M, Myers RP, Messous D, Thibaut V, Imbert-Bismut F, Poynard T. Noninvasive prediction of fibrosis in patients with chronic hepatitis C
2003 Hepatology Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin
2003 Journal of Hepatology Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, Messous D, Charlotte F, Di Martino V, Benhamou Y, Poynard T. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B
2004 Hepatology Le Calvez S, Thabut D, Messous D, Munteanu M, Ratziu V, Imbert-Bismut F, Poynard T The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C
2004 Clinical Chemistry and Laboratory Medecine Imbert-Bismut F, Messous D, Thibaut V, Myers RB, Piton A, Thabut D, Devers L, Hainque B, Mercadier A, Poynard T. Intralaboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.
2004 Nature Medecine Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics
2004 Hepatology Reviews Poynard T, Imbert-Bismut F, Ratziu V Serum markers of liver fibrosis.
2004 Clinical Chemistry Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, Messous D, Thibault V, Benhamou Y, Moussalli J, Ratziu V. Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis C
2004 Comparative Hepatology Munteanu M, Messous D, Thabut D, Imbert-Bismut F, Jouys M, Massard J, Piton A, Bonyhay L, Ratziu V, Hainque B, Poynard T Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest).
2004 Comparative Hepatology Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, Ratziu V, Mercadier A, Benhamou Y, Hainque B Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV-Fibrosure) and necrosis (ActiTest) in patients with chronic hepatitis C
2005 Clinical Chemistry and Laboratory Medecine Ferard G, Imbert-Bismut F, Messous D, Piton A, Ueda S, Poynard T, LessingerJM. A reference material for traceability of aspartate aminotransferase (AST) results.
2005 Clinical Gastroenterology and Hepatology Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, Beuzen F, Capron F, Thabut D, Munteanu M, Chaput JC, Poynard T. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease
2005 Gastroenterology Castéra L, Vergniol J, Foucher J, Brigitte Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, de Lédinghen V. Prospective comparison of transient elastography, Fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C.
2005 Expert Review of Molecular Diagnostics Poynard T, Imbert-Bismut F, Munteanu M, Ratziu V. FibroTest-FibroSURE: towards a universal biomarker of liver fibrosis?
2005 American Journal of Gastroenterology Poynard T, Zoulim F, Ratziu V, Degos F, Imbert-Bismut F, Deny P, Landais P, El Hasnaoui A, Slama A, Blin P, Thibault V, Parvaz P, Munteanu M, Trepo C. Longitudinal assessment of histology surrogate markers (Fibrotest-Actitest) during lamivudine therapy in patients with chronic hepatitis B infection.
2005 Annales de Biologie Clinique Imbert-Bismut F, Messous D, Raoult A, Poynard T, Bertrand JJ, Marie PA, Louis V, Audy C, Thouy JM, Hainque B, Piton A Results transferability on RXL, ARX, X-Pand, BN2 (Dade Behring) and modular DP (Roche Diagnostics) analysers: application to component assays of fibrotest and Actitest
2005 Annales de Biologie Clinique Piton A, Messous D, Imbert-Bismut F, Berges J, Munteanu M, Poynard T, Hainque B. Alpha 2 macroglobulin immunoturbidimetric assays (DakoCytomation reagents) on Roche Diagnostic analysers (Modular P, Cobas Integra). Application to FibroTest-ActiTest.
2005 Gastroenterology Poynard T, Ratziu V, Benhamou Y, Thabut D, Moussalli J. Biomarkers as a first-line estimate of injury in chronic liver diseases: time for a moratorium on liver biopsy?
2005 Clinical Chemistry Poynard T, Ratziu V, Imbert-Bismut F, Munteanu M. Fibrosis biomarkers are not only a formula
2005 Hepatology Cales P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konate A, Gallois Y, Ternisien C, Chevailler A, Lunel F A novel panel of blood markers to assess the degree of liver fibrosis
2005 Hepatology Colletta C, Smirne C, Fabris C, Toniutto P, Rapetti R, Minisini R, Pirisi M. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases.
2005 Comparative Hepatology Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D, Capron D, Abella A, Massard J, Ngo Y, Munteanu M, Mercadier A, Manns M, Albrecht J. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis
2005 Transplantation Varaut A, Fontaine H, Serpaggi J, Verkarre V, Vallet-Pichard A, Nalpas B, Imbert Bismuth F, Lebray P, Pol S Diagnostic accuracy of the fibrotest in hemodialysis and renal transplant patients with chronic hepatitis C virus
2005 Clin Biochem Rosenthal-Allieri MA, Peritore ML, Tran A, Halfon P, Benzaken S, Bernard A. Analytical variability of the Fibrotest proteins
2006 Journal of Viral Hepatitis D’Arondel C, Munteanu M, Moussalli J, Thibault V, Naveau S, Simon A, Messous D, Morra R, Blot C, Poynard T. A prospective assessment of an “a la carte" regimen of PEG Interferon alfa 2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers
2006 BMC Gastroenterology Ratziu V, Massard J, Charlotte F, Messous D, Imbert-Bismut F, Bonyhay L, Tahiri M, Munteanu M, Thabut D, Cadranel JF, Le Bail B, De Ledinghen V, Poynard T, the LIDO Study Group and the CYTOL Study Group Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
2006 Hepatology Castera L, Foucher J, Bertet J, Couzigou P, de Ledinghen V FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases
2006 Hepatology Poynard T, Munteanu M, Ngo Y, Torres M, Benhamou Y, Thabut D, Ratziu V. Diagnostic value of FibroTest with normal serum aminotransferases
2006 American Journal of Gastroenterology Halfon P, Bourliere M, Deydier R, Portal. I, Renou R, Bertrand J, Trana A, Rosenthal A, Rotily M, Sattonet A Independent prospective multicenter validation of biochemical markers (Fibrotest-Actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C.
2006 Clinical Chemistry and Laboratory Medecine Ferard G, Piton A, Messous D, Imbert-Bismut F, Frairi A, Poynard T, Lessinger JM. Intermethod calibration of alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) results: application to Fibrotest and Actitest scores.
2006 Liver International Thabut D, Trabut JB, Massard J, Rudler M, Muntenau M, Messous D, Poynard T. Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study.
2006 Journal of Hepatology Thabut D, Naveau S, Charlotte F, Massard J, Ratziu V, Imbert-Bismut F,Cazals-Hatem D, Abella A, Messous D, Beuzen F, Munteanu M, Taieb J, Moreau R, Lebrec D, Poynard T. The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease.
2006 Journal fo Hepatology Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R, Ferrari A, Alberti A. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.
2006 Hepatology Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, Mehta S, Kirk GD, Nelson K, Afdhal N, Thomas DL Progression of liver fibrosis among injection drug users with chronic hepatitis C.
2006 Clinical Biochemistry Sène D , Limal N, Messous D, Ghillani-Dalbin P, Charlotte F, Halfon P, Jean-Marie Thiollière JM, Piette JC, Imbert-Bismut F, Halfon P, Poynard T, Cacoub P Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis.
2006 American Journal of Gastroenterology Thabut D, Le Calvez S, Thibault V, Massard J, Munteanu M, Di Martino V, Ratziu V, Poynard T Hepatitis C in 6,865 Patients 65 yr or Older: A severe and neglected curable disease?
2006 Haemophilia Maor Y, Bashari D, Kenet G, Lubetsky A, Luboshitz J, Schapiro JM, Penaranda G, Bar-Meir S, Martinowitz U, Halfon P Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
2006 Clinical Chemistry Ngo Y, Munteanu M, Messous D, Charlotte F, Imbert-Bismut F, Thabut D, Lebray P, Thibault V, Benhamou Y, Moussalli J, Ratziu V, Poynard T. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.
2006 BMC Gastroenterology Poynard T, Ratziu V, Charlotte F, Messous D, Munteanu M, Imbert Bismut F, Massard J, Bonyhay L, Tahiri M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V, Group L, Group C. Diagnostic value of biochemical markers (NashTest) for the prediction of NASH in patients with non-alcoholic fatty liver disease.
2006 Journal of Viral Hepatitis Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, Portal I,Lecomte L, Castellani P, Rosenthal-Allieri MA, Gerolami R, Ouzan D, Deydier R, Degott C, Halfon P Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
2007 Alimentary Pharmacology and Therapeutics Ratziu V, Giral P, Munteanu M, Messous D, Mercadier A, Bernard M, Morra R, Imbert-Bismut F, Bruckert E, Poynard T. Screening for liver disease using non-invasive biomarkers (FibroTest-SteatoTest-NashTest-FibroSURE) in patients with hyperlipidaemia
2007 Journal of Hepatology Halfon P, Bacq Y, De Muret A, Penaranda G, Bourliere M, Ouzan D, Tran A, Botta D, Renou C, Brechot MC, Degott C, Paradis V. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.
2007 Alimentary Pharmacology and Therapeutics Poynard T, Halfon P, Castera L, Charlotte F, Bail BL, Munteanu M, Messous D, Ratziu V, Benhamou Y, Bourliere M, Ledinghen VD; the FIBROPACA group. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.
2007 World Journal of Gastroenterology Sebastiani G, Vario A, Guido M, Alberti A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B.
2007 Journal of Hepatology Leroy V, Hilleret MN, Sturm N, Trocme C, Renversez JC, Faure P, Morel F, Zarski JP. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C
2007 Journal of Gastrointestinal and Liver Diseases Grigorescu M, Rusu M, Neculoiu D, Radu C, Aerban A, Caþanao M, Grigorescu MD The FibroTest Value in Discriminating between Insignificant and Significant Fibrosis in Chronic Hepatitis C Patients. The Romanian Experience
2007 Liver International Berends MA, Snoek J, de Jong EM, Van Krieken JH, de Knegt RJ, van Oijen MG, van de Kerkhof PC, Drenth JP. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
2007 Hepatology Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and Fibrotest.
2007 Expert Review of Molecular Diagnostics Morra R, Munteanu M, Imbert-Bismut F, Messous D, Ratziu V, Poynard T. FibroMAX: towards a new universal biomarker of liver disease?
2007 Clinical Chemistry Poynard T, Halfon P, Castera L, Munteanu M, Imbert-Bismut F, Ratziu V, Benhamou Y, Bourliere M, de Ledinghen V, FibroPaca Group. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages.
2007 Alimentary Pharmacology and Therapeutics Thabut D, Imbert-Bismut F, Cazals-Hatem D, Messous D, Muntenau M, Valla DC, Moreau R, Poynard T, Lebrec D. Relationship between the Fibrotest and portal hypertension in patients with liver disease.
2007 Alimentary Pharmacology and Therapeutics Morra R, Munteanu M , Bedossa P, Dargere D, Janneau JL, Paradis V, Ratziu V, Charlotte F, Thibault V, Imbert-Bismut F, Poynard T. Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.
2007 Journal of Viral Hepatitis Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.
2007 The Israel Medical Association Journal Morali G, Maor Y, Klar R, Braun M, Ben Ari Z, Bujanover Y, Zuckerman E, Boger S Halfon P. Fibrotest-Actitest: the biochemical marker of liver fibrosis – The Israeli Experience.
2007 Hepatology Lewin M, Poujol-Robert A, Boelle PY, Wendum D, Lasnier E, Viallon M, GuechotJ, Hoeffel C, Arrive L, Tubiana JM, Poupon R Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.
2007 BMC Gastroenterology Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert-Bismut F, Naveau S, Thabut D, Lebrec D, Zoulim F, Bourliere M, Cacoub P, Messous D, Munteanu M, de Ledinghen V Meta-analyses of Fibrotest diagnostic value in chronic liver disease
2008 Clinical Biochemistry Calès P, Veillon P, Konaté A, Mathieu E, Ternisien C, Chevailler A, Godon A, Gallois Y, Joubaud F, Hubert-Fouchard I, Oberti F, Réaud S, Hunault G, Mauriat F, Lunel-Fabiani F, Reproducibility of blood tests of liver fibrosis in clinical practice
2008 Journal of Pediatric Gastroenterology and Nutrition de Lédinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V,Castéra L, Sandrin L, Merrouche W, Lavrand F, Lamireau T Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy.
2008 Haemophilia Maor Y, Calès P, Bashari D, Kenet G, Lubetsky A, Luboshitz J, Schapiro JM, Pénaranda G, Bar-Meir S, Martinowitz U, Halfon P Improving estimation of liver fibrosis using combination and newer non-invasive biomarker scoring systems in hepatitis C-infected haemophilia patients.
2008 American Journal of Gastroenterology Shaheen AA, Wan AF, Myers RP. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy
2008 Hepatology Morra R, Lebray P, Ingiliz P, Ngo Y, Munteanu M, Ratziu V, Poynard T. FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C
2008 Hepatology Adler M, Gulbis B, Moreno C, Evrard S, Verset G, Golstein P, Frotscher B, Nagy N, Thiry P. The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases.
2008 Journal of Viral Hepatitis Sebastiani G, Vario A, Guido M, Alberti A. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
2008 Journal of Viral Hepatitis Poynard T, Munteanu M, Ngo Y, Moussalli J, Lebray P, Thabut D, Benhamou Y, Ratziu V. FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence
2008 Journal of Hepatology Cacoub P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Halfon P. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The Fibrovic study - ANRS HC02.
2008 Gastroenterologie Clinique et Biologique Rosenthal-Allieri MA, Tran A, Halfon P, Imbert-Bismut F, Munteanu M, Messous D, Peritore ML, Poynard T, Bernard A. Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.
2008 Journal of Thoracic and Cardiovascular Surgery Friedrich-Rust M, Koch C, Rentzsch A, Sarrazin C, Schwarz P, Herrmann E, Lindinger A, Sarrazin U, Poynard T, Schäfers HJ, Zeuzem S, Abdul-Khaliq H. Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers.
2008 HIV Clinical Trials Shaheen AA, Myers RP. Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV/hepatitis C coinfection.
2008 Clinical Gastroenterology and Hepatology Jacqueminet S, Lebray P, Morra R, Munteanu M, Devers L, Messous D, Bernard M, Hartemann-Heurtier A, Imbert-Bismut F, Ratziu V, Grimaldi A, Poynard T. Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes
2008 Alimentary Pharmacology and Therapeutics Bourliere M, Penaranda G, Ouzan D, Renou C, Botta-Fridlund D, Tran A, Rosenthal E, Wartelle-Bladou C, Delasalle P, Oules V, Portal I, Castellani P, Lecomte L, Rosenthal-Allieri MA, Halfon P Optimized stepwise combination algorithms of non invasive liver fibrosis scores including Hepascore in HCV patients.
2008 Liver International Calès P, de Ledinghen V, Halfon P, Bacq Y, Leroy V, Boursier J, Foucher J, Bourlière M, de Muret A, Sturm N, Hunault G, Oberti F Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C
2008 Clinical Biochemistry Munteanu M, Imbert-Bismut F, Messous D, Morra R, Thabut D, Lebray P, Benhamou Y, Ratziu V, Poynard T. Reproducibility of non-invasive fibrosis biomarkers, FibroMeter and FibroTest, could be improved by respecting the analytical standardizations.
2008 PlosOne Ngo Y, Benhamou Y, Thibault V, Ingiliz P, Munteanu M, Lebray P, Thabut D, Morra R, Messous D, Charlotte F, Imbert-Bismut F, Rousselot-Bonnefont D, Moussalli J, Ratziu V, Poynard T An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (Fibrotest-Actitest) and viral load.
2008 European Journal of Gastroenterology and Hepatology Imbert-Bismut F, Naveau S, Morra R, Munteanu M, Ratziu V, Abella A, Messous D, Thabut D, Benhamou Y, Poynard T. The diagnostic value of combining carbohydrate deficient transferin, fibrosis and steatosis biomarkers for the prediction of excessive alcohol consumption.
2008 Journal of Gastrointestinal and Liver Diseases Munteanu M, Ratziu V, Morra R, Messous D, Imbert-Bismut F, Poynard T Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax Experience.
2008 Advances in Clinical Chemistry Poynard T, Morra R, Ingiliz P, Imbert‐Bismut F, Thabut D, Messous D, Muntenau M, Massard J, Benhamou Y, Ratziu V Biomarkers of liver fibrosis
2007 Chinese Journal of Practical Internal Medicine Zhao LR , Xu DJ, Lu ZH, Zhao H, Lang ZW, Wang GQ. Validation of FibroTest to diagnose liver fibrosis to patients with chronic hepatitis B
2008 Hepatology Naveau S, Gaudé G, Asnacios A, Agostini H, Abella A, Barri-Ova N, Dauvois B, Prévot S, Ngo Y, Munteanu M, Balian A, Njiké-Nakseu M, Perlemuter G, Poynard T. Diagnostic and prognostic values of non-invasive biomarkers of fibrosis in patients with alcoholic liver disease.
2008 Journal of Viral Hepatitis Poynard T, Ngo Y, Marcellin P, Hadziyannis S, Ratziu V, Benhamou Y. Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by Hepatitis B Virus.
2008 PlosOne Poynard T, Ingiliz P, Elkrief L, Munteanu M, Lebray P, Morra R, Messous D, Imbert Bismut F, Roulot D, Benhamou Y, Thabut D, Ratziu V. Concordance in a world without a gold standard: A new non-invasive methodology for improving accuracy of fibrosis markers.
2008 Gastroenterol Clin Biol Poynard T, Muntenau M, Morra R, Ngo Y, Imbert-Bismut F, Thabut D, Messous D, Massard J, Lebray P, Moussalli J, Benhamou Y, Ratziu V. Methodological aspects for the interpretation of liver fibrosis non-invasive biomarkers: a 2008 update.
2008 Gastroenterol Clin Biol Halfon P, Munteanu M, Poynard T. FibroTest-ActiTest as a non-invasive marker of liver fibrosis.
2008 Hepatology Poynard et al, Screening for advanced fibrosis using non-invasive biomarkers, FibroTest (FT), and Fibroscan (FS) in a community based population,
2008 Zhonghua Gan Zang Bing Za Zhi Gui HL, Xie Q, Wang H FibroTest-ActiTest for predicting liver fibrosis and inflammatory activity in Chinese patients with chronic hepatitis B.
2008 Aliment Pharmacol Ther Nguyen-Khac E, Chatelain D, Tramier B, Decrombecque C, Robert B, Joly JP, Brevet M, Grignon P, Lion S, Le Page L, Dupas JL. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.
2008 Hepatology Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Zvibel I, Goldiner I, Blendis L, Halpern Z, Oren R Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study
2009 Transplant. Int. Alric L, Kamar N, Bonnet D, Danjoux M, Abravanel F, Lauwers-Cances V, Rostaing L. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis. Transpl Int. 2009 Jan 29. Alric L, Kamar N, Bonnet D, Danjoux M, Abravanel F, Lauwers-Cances V, Rostaing L. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis. Transpl Int. 2009 Jan 29.
2009 Gastroenterol Clin Biol Salles N, Dussarat P, Foucher J, Villars S, de Lédinghen V Non-invasive evaluation of liver fibrosis by transient elastography and biochemical markers in elderly inpatients
2009 Mol Cell Proteomics. Vanderschaeghe D, Laroy W, Sablon E, Halfon P, Van Hecke A, Delanghe J, Callewaert N. GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics.
2009 J Viral Hepat Vergniol J, Foucher J, Castéra L, Bernard PH, Tournan R, Terrebonne E,Chanteloup E, Merrouche W, Couzigou P, de Lédinghen V. Changes of non-invasive markers and FibroScan values during HCV treatment.
2009 Hepatology Sebastiani G, Halfon P, Castera L, Pol S, Thomas DL, Mangia A, Marco VD, Pirisi M, Voiculescu M, Guido M, Bourliere M, Noventa F, Alberti A. SAFE biopsy: A validated method for large-scale staging of liver fibrosis in chronic hepatitisC.
2009 World J Gastroenterol Lau-Corona D, Pineda LA, Aviles HH, Gutierrez-Reyes G, Farfan-Labonne BE, Nunez-Nateras R, Bonder A, Martinez-Garcia R, Corona-Lau C, Olivera-Martinez MA, Gutierrez-Ruiz MC, Robles-Diaz G, Kershenobich D. Effective use of FibroTest to generate decision trees in hepatitis C.
2009 J Hepatol Poynard T, Benhamou Y, Thabut D, Ratziu V. Liver biopsy: the best standard...when everything else fails.
2008 Saudi J Gastroenterol Poynard T, Morra R, Ingiliz P, et al. Assessment of liver fibrosis: noninvasive means

BioPredictive



Address

BioPredictive
40 rue du Bac
75007 Paris
FRANCE

Tel : +33 1 45 44 30 64
email : contact@biopredictive.com


Come meet us

    25-28 mar JFHOD (Paris, France)
    3-4 jun Zilele Stiintifice "Victor Babeş"- editia a-II-a (Bucureşti; Centrul de Diagnostic si Tratament "Victor Babeş"; România)
    9-11 jun Al XXX-lea Simpozion Naţional de Gastroenterologie, Hepatologie si Endoscopie Digestivă (Craiova; România; Universitatea de Medicina si Farmacie)
Upcoming events…
 
Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: